ES2107375A1 - Liquid pharmaceutical formulations of ebastin by the oral route. - Google Patents
Liquid pharmaceutical formulations of ebastin by the oral route.Info
- Publication number
- ES2107375A1 ES2107375A1 ES09501556A ES9501556A ES2107375A1 ES 2107375 A1 ES2107375 A1 ES 2107375A1 ES 09501556 A ES09501556 A ES 09501556A ES 9501556 A ES9501556 A ES 9501556A ES 2107375 A1 ES2107375 A1 ES 2107375A1
- Authority
- ES
- Spain
- Prior art keywords
- ebastin
- liquid pharmaceutical
- pharmaceutical formulations
- oral route
- formulations
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Liquid pharmaceutical formulations of ebastin by the oral route. Liquid pharmaceutical formulations of 4-diphenylmethoxy-1- [3-(4-tert-butylbenzoyl)propyl]piperidine, the common name of which is ebastin, which contain hydroxylated carboxylic acids, non-ionic surfactants and medium-chain polyols in a proportion between 1:1:3:25 and 3:10:25:500, respectively, together with pharmaceutically acceptable excipients or diluents. These formulations are used for the treatment of allergic processes such as rhinitis, urticaria, dermatitis or conjunctivitis.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES9501556A ES2107375B1 (en) | 1995-08-01 | 1995-08-01 | LIQUID PHARMACEUTICAL FORMULATIONS OF EBASTIN BY ORAL WAY. |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES9501556A ES2107375B1 (en) | 1995-08-01 | 1995-08-01 | LIQUID PHARMACEUTICAL FORMULATIONS OF EBASTIN BY ORAL WAY. |
Publications (2)
Publication Number | Publication Date |
---|---|
ES2107375A1 true ES2107375A1 (en) | 1997-11-16 |
ES2107375B1 ES2107375B1 (en) | 1998-07-01 |
Family
ID=8291245
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES9501556A Expired - Fee Related ES2107375B1 (en) | 1995-08-01 | 1995-08-01 | LIQUID PHARMACEUTICAL FORMULATIONS OF EBASTIN BY ORAL WAY. |
Country Status (1)
Country | Link |
---|---|
ES (1) | ES2107375B1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013081562A1 (en) | 2011-10-13 | 2013-06-06 | Mahmut Bilgic | Oral formulations comprising ebastine |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0171331A1 (en) * | 1984-08-03 | 1986-02-12 | Laboratoire Vaillant Defresne | Liquid composition containing quinine formate |
FR2624736A1 (en) * | 1987-12-16 | 1989-06-23 | Dietlin Francois | Novel water-dispersible pharmaceutical compositions based on ornidazole |
WO1992016210A1 (en) * | 1991-03-13 | 1992-10-01 | Rhone-Poulenc Rorer S.A. | Novel liquid compositions based on derivatives of 1,4 substituted piperidine |
ES2052075T3 (en) * | 1989-01-23 | 1994-07-01 | Merrell Dow Pharma | LIQUID PHARMACEUTICAL COMPOSITION FOR DERIVATIVES OF PIPERIDINOALCANOL. |
US5574045A (en) * | 1995-06-06 | 1996-11-12 | Hoechst Marion Roussel, Inc. | Oral pharmaceutical composition of piperidinoalkanol compounds in solution form |
-
1995
- 1995-08-01 ES ES9501556A patent/ES2107375B1/en not_active Expired - Fee Related
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0171331A1 (en) * | 1984-08-03 | 1986-02-12 | Laboratoire Vaillant Defresne | Liquid composition containing quinine formate |
FR2624736A1 (en) * | 1987-12-16 | 1989-06-23 | Dietlin Francois | Novel water-dispersible pharmaceutical compositions based on ornidazole |
ES2052075T3 (en) * | 1989-01-23 | 1994-07-01 | Merrell Dow Pharma | LIQUID PHARMACEUTICAL COMPOSITION FOR DERIVATIVES OF PIPERIDINOALCANOL. |
WO1992016210A1 (en) * | 1991-03-13 | 1992-10-01 | Rhone-Poulenc Rorer S.A. | Novel liquid compositions based on derivatives of 1,4 substituted piperidine |
US5574045A (en) * | 1995-06-06 | 1996-11-12 | Hoechst Marion Roussel, Inc. | Oral pharmaceutical composition of piperidinoalkanol compounds in solution form |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013081562A1 (en) | 2011-10-13 | 2013-06-06 | Mahmut Bilgic | Oral formulations comprising ebastine |
Also Published As
Publication number | Publication date |
---|---|
ES2107375B1 (en) | 1998-07-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MY103352A (en) | Piperazinyl-heterocyclic compounds | |
PL361341A1 (en) | Novel pharmaceutical composition | |
CA2260145A1 (en) | Use of l-acetylcarnitine, l-isovalerylcarnitine, l-propionylcarnitine for increasing the levels of igf-1 | |
ZA967746B (en) | Treatment of tinnitus using neuroprotective agents. | |
NO903911D0 (en) | PROCEDURE FOR THE PREPARATION OF 4-HYDROXYTETRAHYDROPYRAN-2-ON AND THE SIMILAR DIHYDROXYCARBOXYLIC ACID DERIVATIVES, SALTS AND ESTERS, THEIR USE AS MEDICINES, PHARMACEUTICAL PATTERIES AND PHARMACEUTICAL PATTERIES. | |
ES2052065T3 (en) | DISPERSIBLE FORMULATION. | |
KR0148213B1 (en) | Phenyla lkan(en)oic acid and pharmaceutical composition comprising the same | |
GB9310095D0 (en) | Therapeutic compounds | |
IT1283225B1 (en) | STRAINS OF BACTERIA, PHARMACEUTICAL COMPOSITION CONTAINING ONE OR MORE OF SUCH STRAINS AND USE OF THE SAME FOR THE PREVENTION AND THERAPY OF | |
NO973912L (en) | Preventive or therapeutic drug for Alzheimer's disease | |
MY103210A (en) | Arylpiperazinyl-alkylene-phenyl-heterocyclic compounds. | |
PT790236E (en) | 5- (2- (4- (1,2-BENZISOYZAZOL-3-YL) -1-PYRAZAZYL) -ETHYL-6-CHLORO-1,3-DIHYDRO-2H-INDOL-2-ONA | |
CA2135709A1 (en) | Melatonin derivatives for use in treating sleep disorders | |
PH31643A (en) | 2-Oxidole-1-carboxamide pharmaceutical agents for the treatment of alzheimer's disease. | |
ES2107375A1 (en) | Liquid pharmaceutical formulations of ebastin by the oral route. | |
PT1152762E (en) | USE OF DEOXYGEGANIN IN THE TREATMENT OF ALZHEIMER'S DEMENTIA | |
EP0618812A4 (en) | Use of protease nexin-i as an antiinflammatory. | |
DK0657431T3 (en) | 4-Phenyl-3-substituted 1,4-dihydropyridine esters with cerebral action. | |
DK47988D0 (en) | SUBSTITUTED 3-PHENYL-7H-THIAZOLOOE3,2-BAAOE1,2,4AATRIAZIN-7-ONER, THEIR PREPARATION AND APPLICATION AS MEDICINAL PRODUCTS, AND THE PRODUCTS USED INTERMEDIATELY | |
DE58902264D1 (en) | BETA LACTAM ANTIBIOTICS, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS AND IN MEDICINAL PRODUCTS. | |
GR3018126T3 (en) | 4-[(Thiophene-2-carbonyl)oxy]pyrrolidine-2-carboxylic acid, its preparation and its use as anti-inflammatory and anti-dystrophic agent. | |
IT9082655A0 (en) | PERFECTED EQUIPMENT FOR THE TREATMENT OF VISUAL DEFECTS, PARTICULARLY FOR ANXIOMETROPIC AND STRABIBLE ANBLIOPIA AND SOME CORTICAL LESIONS. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EC2A | Search report published |
Date of ref document: 19971116 Kind code of ref document: A1 Effective date: 19971116 |
|
PC2A | Transfer of patent | ||
FD2A | Announcement of lapse in spain |
Effective date: 20180806 |